, Tracking Stock Market Picks
Enter Symbol:
Hospira Inc (HSP) [hlAlert]

down 66.73 %

Hospira Inc (HSP) rated Underweight with price target $32 by Barclays

Posted on: Thursday,  Feb 14, 2013  2:25 PM ET by Barclays

Barclays rated Underweight Hospira Inc (NYSE: HSP) on 02/14/2013, when the stock price was $29.91. Since
then, Hospira Inc has gained 200.64% as of 09/01/2015's recent price of $89.92.
If you would have followed this Barclays's recommendation on HSP, you would have lost 66.73% of your investment in 929 days.

Hospira Inc is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness by developing, manufacturing and marketing products that help improve the safety and efficacy of patient care. Their portfolio includes one of the industry's broadest lines of generic acute-care injectables, integrated solutions for medication management and infusion therapy, and a full-service contract manufacturing business.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/14/2013 2:25 PM Sell
29.91 32.00
as of 12/13/2013
1 Week up  4.06 %
1 Month down  -1.39 %
3 Months down  -0.65 %
1 YTD down  -33.33 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy